Clinical Trial

Clinical Study of the Use of Amino Acid Peritoneal Dialysate in Diabetic Patients

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 22, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The study is a single center, open, prospective, self controlled clinical study. The patients with diabetes who are to be enrolled in peritoneal dialysis are to observe the changes of glycosylated hemoglobin relative to the baseline 90 days after using amino acid (15) peritoneal dialysis solution.
Trial Details
NCT Number NCT07077538
Lead Sponsor The People's Hospital of Gaozhou
Collaborators: Chengdu Qingshan Likang Pharmaceutical Co., Ltd
Conditions Peritoneal Dialysis, Diabetes
Enrollment 70 participants
Start Date 2025-07-30
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-22